In this paper, 791 #COVID19 positive people were contact traced AND universal testing was recommended for their close contacts.
Ultimately only 120 people were discovered.
2/
If COVID has an R of ~1.3… those 791 people perhaps led to >1000 additional cases.
If 120 were discovered... ~900 were not.
And this was an organized operation.
3/
Further, it is very likely those 791 people made up only a fraction of the actual positive cases that could have been traced at that time…
It’s possible we find only 10% of actual cases in many places to even start the contact tracing on...
4/
Further, the fraction (120) that were discovered were likely found late, many after infecting others.
Time from a symptomatic case to have symptoms to when contact tested was 4-10+ days.
Likely many contacts obtained results 6-15 days after the case became symptomatic.
5/
Moreso, because many cases were actually asymptomatic, they likely didn’t even get their first PCR test until AFTER they were infectious
So the time from first being infectious to the contacts getting tested could be weeks or more for many.
6/
So overall, though 120 positive contacts were discovered through intense contact tracing, many of the contacts may have already themselves gone on to transmit.
Overall, a LOWER bound of 900 were very likely to have never been detected.
7/
Also, given the 791 constituted only a fraction of true positives at the time they were detected (because limited / inconvenient testing), the true number of new cases not detected in the collective weeks after the cases were identified could have been multiple 1000’s
8/
With high #COVID19 cases, we need different models for public health.
Lab based testing / contact tracing can’t work with high cases for this virus.
As this paper showed, delays and massive under detection of infecteds means the effort just scratches the surface.
9/
To be clear, when cases are low and contact tracing resources plentiful, contact tracing can be very powerful.
But we shouldn’t let the ways that we’ve always done this dictate the ways we must deal with a fast global pandemic today.
10/
I think a new era of massively distributed at-home rapid tests are our best hope to limit spread without massive lockdowns.
We should push for these so we can bring outbreaks under control & return to a semblance of normalcy as soon as we can – before vaccines.
11/11
Also, we do have different somewhat less conventional options for contact tracing that *could* work better.
Backwards contact tracing is a different approach than conventional contact tracing, with greater efficiency for a quick moving virus like this
The specificity of the PanBio, BinaxNow and SD Biosensor tests (the three leading manufactured rapid tests in the world) are looking very good!
In this paper, specificity was 100% in >400 samples... thus >99.2%
Now multiple studies showing very high specificity!
2/
The sensitivity metrics AND specificity metrics are now completely in alignment with what we have proposed for frequent rapid testing that can control outbreaks without vaccines.
In light of the recent article from the UK discussing antibody waning - it’s important to read additional reports that show that while the antibodies are waning, they are not disappearing. This is expected and the natural course of an immune response.
After a primary infection, antibodies go sky high - along with the cells that produce them - and then after the virus clears, those cells must subside and the antibody production falls. Antibodies this wane, almost by definition, after a primary infection
2/
Importantly, the antibodies do go down and, like in the UK report may fall below the limit of detection. But like in the @SciImmunology paper above by @florian_krammer among others, when a more sensitive test is used, they often remain detectable...
3/
New paper showing strong agreement between nasal (ie self collection) and nasopharyngeal swab on rapid test. This is an important finding since, in US, rapid tests currently authorized for nasopharyngeal swabs and thus need healthcare collections
These types of studies are needed to identify how well rapid antigen tests may work with self collected swab - essential for wide distribution and public health screening use of these tests to help curb outbreaks.
Other notable items from this paper:
2/
One is that the rapid antigen tests in this paper (SD Biosensor) performed very well up to a Ct of about 30. This is what we have expected for these tests and is likely at this rate to capture most infections with viable virus. Great for a public health screening test
3/
Eli Lilly’s antibody therapy unfortunately is not working in hospitalized patients. A blow to a hopeful “remedy” that could help tip the balance between risk of infections vs risk of economic fallout
But this isn’t the last of this story.. not by far
First, there are other antibody based therapies that are being developed, are in trials and new versions in early R&D phase.
Monoclonal antibodies have a huge potential and we mustn’t let this get us down.
2/
Regeneron’s monoclonal antibody therapy for example (the drug given to the president) remains in trials for hospitalized patients. This is but one of many that will be in trials!
3/
For the 14 day average change to >double in only 3 days means that the actual current change is much more than 15% (to pull a 14-day change that far up in only 3 days means the past three days have seen remarkably large increases).
2/
This is not some fear tactic. This is peoples lives. This is the proper functioning of our healthcare system (already stretched to the brim at baseline).
We are only at the beginning of this “spike” and it could continue accelerating up for months!
3/